13973-87-0 Usage
Chemical Properties
Crystals or red liquid. A strong oxidizing agent.
Uses
Different sources of media describe the Uses of 13973-87-0 differently. You can refer to the following data:
1. Bromine azide (BrN3) is a strong oxidizing agent that will explode when shocked or heated.
It is used to make detonators for dynamite and other explosives.
2. Detonators and other explosive devices.
Hazard
Explosive when heated or shocked. Will
ignite combustible materials on contact.
Safety Profile
A poison. Can explode
spontaneously. The solid, liquid and vapor
are shock-sensitive explosives. Concentrated
solutions in organic solvents may explode.
Moderate fire hazard in the form of vapor
by chemical reaction. A powerful oxidant.
Moderately explosive when exposed to heat.
The liquid explodes on contact with arsenic,
sodium, silver foil, or phosphorus.
Incompatible with Sb, ethyl ether, Ag,
metals. When heated to decomposition it emits highly toxic fumes of Brand
explodes. See also BROMINE and
AZIDES.
Check Digit Verification of cas no
The CAS Registry Mumber 13973-87-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,9,7 and 3 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 13973-87:
(7*1)+(6*3)+(5*9)+(4*7)+(3*3)+(2*8)+(1*7)=130
130 % 10 = 0
So 13973-87-0 is a valid CAS Registry Number.
InChI:InChI=1/BrN3/c1-3-4-2
13973-87-0Relevant articles and documents
Solid-state structure of bromine azide
Lyhs, Benjamin,Blaeser, Dieter,Woelper, Christoph,Schulz, Stephan,Jansen, Georg
, p. 1970 - 1974 (2012)
A new twist: The single-crystal structural analysis of BrN3 is described. In contrast to IN3, which forms chains, BrN3 forms a helical structure in the solid state (see picture). Such a structural feature has not been previously observed in covalent p-block azide chemistry.
Antineoplastic heteronapthoquinones
-
, (2008/06/13)
This invention relates to a naphthoquinone derivatives, to processes and to intermediates for preparing these derivatives, to pharmaceutical composition and to the use of these derivatives as antitumor agents in mammals.
